Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-097809
Filing Date
2021-07-29
Accepted
2021-07-29 20:51:20
Documents
2
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2123556-3_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2123556-3_3seq1.xml 3 7916
2 EXHIBIT 24 tm2123556d3_ex24.htm EX-24 9145
  Complete submission text file 0001104659-21-097809.txt   18446
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Issuer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNEERING CORPORATION 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address
Hall Brett Matthew (Reporting) CIK: 0001870437 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40675 | Film No.: 211129533